Aero Red

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aero Red

Property Description
Active Ingredient Simethicone (Polydimethylsiloxane)
Form Oral drops and chewable tablets
Pharmacological Class Gastrointestinal Agent, Antiflatulence Agent
Common Use Relief of bloating and gas discomfort
Origin Synthetic silicone derivative

What Type of Medicine is Aero Red and What Does it Contain?

Aero Red is a brand-name pharmaceutical preparation classified as a Gastrointestinal Agent, specifically designated as an Antiflatulence Agent, intended solely to relieve symptoms associated with excess gas in the digestive tract. The product’s sole active ingredient is Simethicone, the International Nonproprietary Name (INN) for activated Polydimethylsiloxane. Simethicone is a synthetic compound derived from silicone polymers, which operates through a purely physical mechanism within the gut lumen and is not absorbed into the bloodstream. This fact confirms that the medicine works locally in the digestive system and does not enter the general circulation.


General Purpose and Delivery of the Active Ingredient

The general purpose of Aero Red is to provide relief from abdominal pressure, bloating, and discomfort caused by excess gas, such as flatulence and meteorism. Aero Red is clinically recognized for targeting the physical cause of gas buildup in the digestive system. The formulation is available in distinct oral dosage forms, including oral drops (a liquid suspension often favored for infants and young children) and chewable tablets (suitable for adults), necessary for the efficient and complete delivery of Simethicone to the gastrointestinal tract.


Simethicone: The Mechanism of Gas Reduction

Simethicone is effective because it acts as a surface-active substance (a surfactant), significantly lowering the surface tension of gas bubbles trapped in the stomach and intestines. This physical action causes the numerous small, stable gas bubbles, which contribute to the painful sensation of distention, to coalesce (merge) into larger, free gas pockets. This conversion facilitates the body's natural processes of gas elimination, either through eructation (belching) or flatus (passing gas), providing direct relief from pressure.

What side effects are possible with Aero Red?

Possible Side Effects and Safety Information

The safety profile of Simethicone, the active ingredient in Aero Red, is defined by its non-systemic mechanism; the compound acts locally in the gastrointestinal tract and is not absorbed into the bloodstream. This characteristic limits the scope of officially documented adverse reactions primarily to the gut and rare systemic responses, as classified in regulatory documents.


Adverse Reaction Scope

Category Description
System-Organ Classes Effects are mainly reported under Gastrointestinal Disorders (e.g., nausea, constipation) and Immune System Disorders (systemic allergic reactions).
Frequency Classification Many post-marketing reports, including gastrointestinal effects, are assigned a frequency of Not Known (cannot be estimated from available data). Allergic reactions are classified as Rare or Very Rare.
Serious Adverse Reactions Officially documented serious reactions involve systemic hypersensitivity, specifically anaphylactic reaction and angioedema.

Safety Considerations and Restrictions

Regulatory documents include high-level safety constraints for use. Simethicone is contraindicated in individuals with a known allergy to the active substance or excipients, or in cases of known or suspected intestinal obstruction or intestinal perforation.

While formulations are authorized for use in infants and children, a specific safety note highlights the potential for reduced absorption of concurrently administered thyroid hormones (e.g., levothyroxine) due to Simethicone's physical effect within the digestive tract. The official safety framework is based on government-approved labeling from authorities such as the EMA and FDA.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents state that an overdose of Aero Red (Simethicone) is not expected to produce systemic toxicity. This is because the compound acts solely as a non-systemic agent and is not absorbed into the bloodstream from the gastrointestinal tract. Consequently, systemic clinical manifestations such as cardiovascular, neurological, or metabolic effects are not documented or anticipated following excessive ingestion.


Documented Risks and Emergency Actions

The primary serious outcome documented in relation to Simethicone is the potential for a severe allergic reaction (hypersensitivity). Urgent medical help must be sought immediately if an overdosage is suspected or if signs of a severe allergic reaction, such as swelling of the face, lips, tongue, or throat, or difficulty breathing, are observed.

Regulatory guidance mandates that individuals seek emergency medical attention or call the Poison Help line for any suspected overdosage scenario. No specific antidote is known for Simethicone overdose. Management is non-specific and supportive, primarily involving discontinuing the medication. No specialized systemic monitoring, such as serum level checks, is required due to the non-absorption of the compound.

Therapeutic Uses of Aero Red

Aero Red is relevant for providing symptomatic relief across domains involving heightened patient distress due to gas accumulation. Simethicone is commonly used to help manage symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. The medication is commonly used across conditions presenting with acute episodes characterized by episodic or fluctuating symptom patterns, particularly abdominal distention, flatulence, and general gas discomfort. It is applied in contexts where temporary, physical support for symptom management is needed, aiming to help ease the overall burden of uncomfortable manifestations.

“It is relevant when supportive symptom management is appropriate, particularly for vulnerable groups, supporting patients during episodes of heightened discomfort.”

Aero Red is applicable in managing physical symptoms related to physical discomfort arising from excess trapped gas, and may assist with the discomfort and pain associated with retained wind. This includes providing assistance in managing the gas component of infantile colic and assisting with the symptomatic management of postoperative gas retention.


Quick Fact: Relief for Bloating and Abdominal Pressure

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Eligibility for using Aero Red (Simethicone) is strictly governed by age, formulation, and specific gastrointestinal conditions as defined in regulatory labeling.

Classification Population/Condition
Absolute Contraindication Known or suspected intestinal obstruction or perforation [Source 3.3].
Absolute Contraindication Documented hypersensitivity or allergy to Simethicone or any excipient [Source 3.3].
Not Recommended Children under 18 years for certain chewable tablet formulations [Source 3.1].
Conditional Use Pregnant or breastfeeding individuals must consult a doctor or pharmacist prior to use [Source 3.3].
Conditional Use Patients with a known intolerance to specific sugars (e.g., sucrose, glucose) due to excipient content [Source 3.3].
Permitted Use Adults and adolescents (chewable tablets); Infants and young children (oral drops) [Source 2.5, 3.3].
No Restrictions Documented Patients with renal or hepatic impairment (consistent with the drug's non-systemic nature) [Source 2.5].

The official profile establishes strict prohibitions for conditions affecting the gut's physical structure. Eligibility for pediatric and adolescent populations is dependent on the specific formulation (drops versus tablets), and use during pregnancy or lactation always requires mandatory consultation with a healthcare professional.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Aero Red, which contains the active ingredient Simethicone, has a simplified interaction profile because it is not absorbed into the bloodstream. It is chemically inert and acts only locally within the gastrointestinal (GI) tract to reduce gas bubbles. Therefore, it does not participate in systemic interactions involving liver enzymes (CYP) or drug transporters.

Simethicone's primary documented interaction is a physical one where it can bind to the surface of other orally administered medicines. This binding may reduce the amount of the co-administered drug that is absorbed into the body, potentially lowering its therapeutic effectiveness.


Documented Pharmacokinetic Interaction

The most important clinically documented interaction involves oral thyroid hormone preparations, such as levothyroxine. Official regulatory information states that co-administration of Simethicone can decrease the systemic absorption of levothyroxine.

To manage this interaction, a timing separation between doses is required. Patients must separate the administration of Simethicone and their thyroid medication to ensure the full dose of the thyroid hormone is absorbed.


Other Potential Local Interactions

Simethicone may also interfere with other medications that have large surface areas, such as cholestyramine (a bile acid sequestrant). The combination is not absolutely prohibited but may necessitate close monitoring or a separation of administration times to maintain the efficacy of the interacting drug. No specific interactions with food, alcohol, or herbal products are documented in official regulatory labeling.

Mechanism of Action

Physical Modulation of Surface Tension and Gas Foam

The active ingredient, Simethicone, functions strictly as a surface-active agent within the gastrointestinal lumen. It does not engage biological targets like receptors or enzymes, but instead acts directly on the physical properties of the trapped gas. Specifically, it significantly lowers the surface tension that stabilizes the countless small, foamy gas bubbles in the gut. This mechanical action destabilizes the gas foam, functionally altering the physical state of the gas within the lumen.

Coalescence Cascade and Facilitation of Gas Elimination

The reduction in surface tension immediately triggers a coalescence cascade, causing the multitude of small, stable bubbles to quickly merge into fewer, much larger pockets of free gas. This physical change results in gas pockets that are mobile and subject to transport and expulsion via eructation (belching) or flatus by normal peristaltic mechanisms. This local mechanism results in a physiological consequence involving the reduction of the physical volume and localized mechanical pressure exerted by the trapped gas foam.

Dosage and Administration Information

How to Use Aero Red

This section outlines the administration instructions for Aero Red (simeticone). These instructions detail the required procedural steps for correct use and are to be followed as described.


Administration Procedure

  • Route of Administration: The medicine is for oral use as a chewable tablet.
  • Preparation: Each tablet must be chewed thoroughly before being swallowed. Do not swallow the tablet whole.
  • Timing: The medicine is to be taken after each main meal.
  • Duration: Use of the medicine should not exceed 10 consecutive days. If symptoms continue or worsen after this period, consultation with a healthcare professional is mandatory.

Official Dosing Schedule

Age Group Typical Dose (120 mg strength) Maximum Daily Dose (120 mg strength)
Adults 1 chewable tablet after each main meal. 4 chewable tablets (480 mg)
Children over 12 years 1 chewable tablet after each main meal. 4 chewable tablets (480 mg)
Children 6–12 years 1 chewable tablet after a main meal. 200 mg total

The instructions specify that the chewable format and post-meal timing are essential components of the protocol for using this medicine. The strict adherence to the maximum daily dose and 10-day treatment limit defines the standardized, short-term usage structure of the drug. No therapeutic uses, benefits, side effects, or mechanism of action are included in this administration guide.

Recent Clinical Evidence

Evidence for Symptomatic Relief of Gas-Related Discomfort

Research has explored how Simethicone was studied for use in adults experiencing symptoms of gas retention, such as bloating, abdominal fullness, and pressure. The available research is primarily derived from short-term Randomized Controlled Trials (RCTs) and subsequent analyses that were applied in studies examining patient-reported experiences. These studies typically monitored patient-reported outcomes describing perceived discomfort over defined time intervals.

The findings derived from this research describe patterns related to numerical changes measured during the study period in these outcomes related to physical discomfort. However, when research describes comparisons against a placebo (an inactive substance), the reported results were often mixed, with some trials observing non-significant differences in the main symptom endpoints. The evidence base contributes to understanding symptom patterns but long-term effects are not fully established and apply only to the adult populations studied during these short timeframes.


Evidence for Use in Specialized Clinical Contexts

Research on Infantile Colic

Simethicone was studied for its potential use in infants with colic. Studies in this area, including Systematic Reviews and clinical trials, research examined short-term symptom changes, focusing on objective changes in the total duration of daily crying.

Studies reported that the objective measure of crying duration did not show a significant difference when compared to infants who received a placebo. However, patterns in parental reports of perceived discomfort were also observed. Overall, the data in this field are still emerging, and certainty remains low regarding objective outcomes.

Research for Diagnostic Procedures

In a distinct research scenario, Simethicone was evaluated in clinical trials for its use as a preparation for certain diagnostic examinations, such as endoscopy and colonoscopy. In this context, scores on indices measuring mucosal clarity during the procedure were observed when Simethicone was used. Research suggests that its use was associated with observations in the total time needed to complete the diagnostic procedure.


Evidence Gaps and Areas of Scientific Uncertainty

The research landscape is characterized by several known limitations. For general gas-related discomfort, follow-up durations were limited, meaning there is limited information for long-term outcomes. Additionally, comparative evidence is lacking for its use alongside non-pharmacological interventions in colic. Overall, findings describe group patterns, not personal outcomes, and research provides context but not individual predictions.

Key Studies & References Simethicone - StatPearls - NCBI Bookshelf

Frequently Asked Questions (FAQ)

Common questions about Aero Red (FAQ)

Q: How quickly does Aero Red typically start to work?

The active ingredient acts only locally in the gut through a physical mechanism, which is associated with a rapid effect. Official product information often emphasizes that chewing the tablet thoroughly is specified as an important part of the protocol to facilitate the intended physical action.

Q: How long do the effects of Aero Red generally last?

Regulatory descriptions indicate that the active ingredient has a short duration of action. This is the reason official administration instructions specify administration multiple times a day (after meals and at bedtime), as needed for symptom relief.

Q: Can Aero Red be taken long-term according to official sources?

Official administration instructions for symptomatic relief with the chewable tablet is defined by the official labeling as not exceeding 10 consecutive days. Regulatory information advises consultation with a healthcare professional if gas symptoms continue or worsen after this period.

Q: Are there any reported interactions between Aero Red and alcohol?

Regulatory labeling does not document any specific interactions between the active ingredient, Simethicone, and alcohol. The medicine works locally in the digestive system and is not absorbed into the bloodstream.

Q: Are there concerns about using Aero Red during pregnancy, according to official data?

The active ingredient is not absorbed into the bloodstream, meaning systemic exposure is minimal. However, official regulatory labeling advises pregnant individuals to consult a healthcare professional or pharmacist prior to using the medicine.

Q: Can breastfeeding women use Aero Red?

Studies and official information state that the active ingredient is not absorbed into the body and therefore cannot be transferred into breast milk. Despite the lack of systemic absorption, regulatory documents still advise breastfeeding women to consult a healthcare professional before using the product.

Q: Is the active substance in Aero Red known to cause dependence?

The active ingredient is classified as a physical agent and is not a controlled medication in regulatory schedules. Because the medicine acts purely locally within the digestive tract and is not absorbed into the body, it does not carry a risk of dependence.

Q: Can Aero Red be taken by people with diabetes?

Official product labeling for some formulations lists intolerance to certain sugars as a contraindication, which is due to the inactive ingredients (excipients). Official information indicates that individuals with diabetes may need to review the product labeling for sugar content and consult a healthcare professional due to the contraindication.

Q: What are the official recommended age limit for using Aero Red?

The authorized age limit depends on the specific product formulation. For symptomatic relief with the chewable tablet, eligibility is typically restricted to adults and adolescents (often 12 or 18 and older). Regulatory information indicates that other forms, such as oral drops, are authorized for permitted use in infants and young children.

Q: Can people with liver or kidney issues use Aero Red?

Due to the active ingredient's non-systemic nature—it is not absorbed into the bloodstream—regulatory documents confirm that no specific restrictions or dosage adjustments are documented for people with pre-existing liver or kidney conditions.

Q: Is Aero Red the same as other medicines for gas or bloating?

Aero Red is classified as an Antiflatulence Agent containing Simethicone. It works via a physical mechanism to reduce gas bubbles (anti-foaming). This mechanism is distinct from other classes of gastrointestinal medicines, such as antacids or activated charcoal, which have chemical or absorbent mechanisms.

Q: Why is Aero Red sometimes recommended before medical imaging procedures?

The active ingredient has been evaluated in a distinct research scenario for its use in preparing for certain diagnostic procedures, such as endoscopy or colonoscopy. Studies indicate that its physical action helps to clear gas bubbles and foam that can potentially obscure the view of the intestinal lining during the procedure.

Q: Is it true that Aero Red does not get absorbed into the bloodstream?

Yes, this is confirmed by official pharmacological descriptions. The active ingredient, Simethicone, works locally in the gastrointestinal tract to break down gas bubbles and is not absorbed into the bloodstream. It is passed out of the body unchanged.

Q: Is Aero Red suitable for people who are following a low-sodium diet?

The active ingredient itself is not restricted for a low-sodium diet, but suitability depends on the inactive ingredients (excipients) in the specific product formulation. Suitability may require reviewing the product labeling for sodium content in the inactive ingredients and consulting a healthcare professional.

Q: What is the difference between Aero Red and antacids?

Aero Red is classified as an Antiflatulence Agent which works purely physically to break up gas foam in the intestines. Antacids belong to a separate pharmacological class and work chemically to neutralize or reduce stomach acid.

Q: Does Aero Red have a warning for people with allergies?

Yes. Official safety information specifies that the medicine is contraindicated (must not be used) if an individual has a known allergy or hypersensitivity to the active substance or any other ingredients. Documented serious adverse reactions include rare cases of systemic allergic reactions.

Q: Is it normal for Aero Red to not work immediately for everyone?

Research evidence from clinical trials suggests that there can be variability in reported outcomes regarding gas-related discomfort among different individuals. Official information describes general group patterns observed in studies, not personal predictions or guarantees of immediate relief.

Q: Does Aero Red contain lactose or sugar?

The presence of excipients like lactose or sugars depends on the specific product formulation (e.g., drops often differ from chewable tablets). Official labeling for some formulations includes a contraindication for intolerance to certain sugars, indicating that those products contain sugar-based ingredients. Official information requires review of the product's full ingredient list for specific excipients.

Q: Does Aero Red interact with common painkillers?

Official regulatory documents list specific interactions with oral thyroid hormones (such as levothyroxine) and potentially cholestyramine. However, no specific interaction warnings with common over-the-counter painkillers are documented in authoritative sources.

Q: Is Aero Red commonly known by any other brand names internationally?

Yes, the active ingredient, Simethicone, is the International Nonproprietary Name (INN) for the substance and is marketed and sold internationally under a large number of different brand names (e.g., Gas-X, Infacol). It is also frequently included as an ingredient in combination products.

Q: Is it okay if I miss a dose of Aero Red?

Patient information often advises that if a dose is missed and it is almost time for the next scheduled dose, regulatory patient information specifies that the individual should typically skip the missed dose and return to the regular administration schedule. It is specified that the individual should not take a double dose to make up for a missed one.

Q: Is there a maximum recommended duration of treatment with Aero Red?

For symptomatic relief of gas, official administration instructions for the chewable tablet specify that the maximum recommended duration of treatment is 10 consecutive days. Regulatory information advises consultation with a healthcare professional if symptoms persist or worsen after this period.

Q: What happens if you stop taking Aero Red suddenly?

Since the medicine is not absorbed into the bloodstream and acts purely physically within the digestive tract, there are no known regulatory warnings or documented effects related to stopping the medicine suddenly.

Q: Is Aero Red known to cause drowsiness?

Regulatory documents do not list drowsiness as a common or expected side effect of the medicine. However, symptoms such as sudden dizziness or drowsiness are listed as potential signs of a rare, serious allergic reaction that would require immediate medical attention.

Q: Why do some people take Aero Red before bedtime?

Official administration instructions commonly advise taking the medicine after meals and at bedtime as part of the recommended schedule. Taking a dose at night is intended to provide relief from gas symptoms that may build up and cause discomfort during sleep.

Q: Are there any studies comparing Aero Red to placebo?

Yes. The research evidence supporting the use of the active ingredient includes Randomized Controlled Trials (RCTs). These studies have examined comparisons of reported outcomes against a placebo (an inactive substance) in adults experiencing gas-related discomfort.

Q: Can you drive or operate machinery while taking Aero Red?

Due to the active ingredient's mechanism of action—it is not absorbed into the bloodstream—official regulatory documents generally indicate no known impact or restriction on the ability to drive or operate machinery.

Q: Does regulatory information state that Aero Red is safe for infants?

Regulatory documents authorize formulations (typically oral drops) containing the active ingredient for permitted use in infants and young children for the symptomatic relief of gas. Official information requires strict adherence to the specific formulation and dosage authorized by the regulatory body.

How should Aero Red be stored and disposed of?

How to Store and Dispose of Aero Red?

The storage and disposal of Aero Red (Simethicone) must strictly follow the official regulatory guidelines to maintain product quality and ensure safety.


Official Storage Conditions

Requirement Specification
Temperature Limit Do not store above 30°C (eighty-six degrees Fahrenheit).
Protection Keep the medicine in the original container and protect it from excess heat and moisture.
Shelf-Life Do not use the product after the expiry date printed on the package.
Child Safety Keep this product out of the sight and reach of children.

Disposal Instructions

Unused or expired Aero Red must not be thrown into household trash or flushed down the toilet. Disposal must be managed through designated pharmaceutical waste collection points, such as those found at a pharmacy, in compliance with local environmental laws. The aim is to avoid discharge into the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aero Red found in:

A-Z Index: